| Primary |
| Drug Use For Unknown Indication |
19.2% |
| Peripheral Vascular Disorder |
9.6% |
| Diabetes Mellitus |
8.2% |
| Hypertension |
8.2% |
| Peripheral Arterial Occlusive Disease |
6.8% |
| Arrhythmia |
5.5% |
| Product Used For Unknown Indication |
5.5% |
| Type 2 Diabetes Mellitus |
5.5% |
| Intermittent Claudication |
4.1% |
| Alcoholic Hepatitis |
2.7% |
| Cardiovascular Disorder |
2.7% |
| Coronary Artery Disease |
2.7% |
| Gout |
2.7% |
| Hypercholesterolaemia |
2.7% |
| Limb Discomfort |
2.7% |
| Sudden Hearing Loss |
2.7% |
| Suicide Attempt |
2.7% |
| Tinnitus |
2.7% |
| Coronary Artery Bypass |
1.4% |
| Hepatitis Alcoholic |
1.4% |
|
| Pain In Extremity |
10.7% |
| Therapeutic Response Unexpected With Drug Substitution |
10.7% |
| Hallucination, Auditory |
7.1% |
| Osteonecrosis Of Jaw |
7.1% |
| Pancreatitis Relapsing |
7.1% |
| Pruritus Generalised |
7.1% |
| Abdominal Wall Haematoma |
3.6% |
| Acute Generalised Exanthematous Pustulosis |
3.6% |
| Biopsy Bone Marrow Abnormal |
3.6% |
| Clonic Convulsion |
3.6% |
| Condition Aggravated |
3.6% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
3.6% |
| Eructation |
3.6% |
| Eye Pruritus |
3.6% |
| Headache |
3.6% |
| Hypotension |
3.6% |
| Hypovolaemic Shock |
3.6% |
| Oedema Peripheral |
3.6% |
| Pain |
3.6% |
| Pancreatitis Acute |
3.6% |
|
| Secondary |
| Product Used For Unknown Indication |
19.7% |
| Diabetes Mellitus |
8.6% |
| Anticoagulant Therapy |
6.8% |
| Drug Use For Unknown Indication |
6.8% |
| Type 2 Diabetes Mellitus |
6.1% |
| Hypertension |
5.9% |
| Oedema |
5.6% |
| Alanine Aminotransferase Increased |
4.7% |
| Drug Exposure During Pregnancy |
4.7% |
| Oedema Peripheral |
4.3% |
| Antiplatelet Therapy |
3.9% |
| Hepatic Enzyme Increased |
3.8% |
| Atrial Fibrillation |
3.4% |
| Blood Cholesterol Increased |
2.5% |
| Dementia Alzheimer's Type |
2.3% |
| Thrombosis Prophylaxis |
2.3% |
| Arrhythmia |
2.2% |
| Ischaemic Cardiomyopathy |
2.2% |
| Myalgia |
2.2% |
| Rhinitis |
2.2% |
|
| Oedema Peripheral |
13.2% |
| Renal Failure Acute |
7.9% |
| Cardiac Tamponade |
6.6% |
| Thrombocytopenia |
6.6% |
| Cerebrovascular Accident |
5.3% |
| Drug Interaction |
5.3% |
| International Normalised Ratio Increased |
5.3% |
| Multi-organ Failure |
5.3% |
| Pulmonary Embolism |
5.3% |
| Sepsis |
5.3% |
| Abdominal Wall Haematoma |
3.9% |
| Coma |
3.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.9% |
| Muscle Haemorrhage |
3.9% |
| Overdose |
3.9% |
| Pneumonia |
3.9% |
| Anaemia |
2.6% |
| Cardiac Failure |
2.6% |
| Cerebral Haemorrhage |
2.6% |
| Gastrointestinal Disorder |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Drug Use For Unknown Indication |
19.8% |
| Hypertension |
11.1% |
| Diabetes Mellitus |
5.8% |
| Type 2 Diabetes Mellitus |
3.9% |
| Multiple Sclerosis |
3.7% |
| Behcet's Syndrome |
3.0% |
| Depression |
2.8% |
| Pain |
2.6% |
| Atrial Fibrillation |
2.6% |
| Rheumatoid Arthritis |
2.4% |
| Prophylaxis |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Cardiac Disorder |
2.2% |
| Non-small Cell Lung Cancer |
2.1% |
| Diabetic Retinopathy |
1.8% |
| Thrombosis Prophylaxis |
1.7% |
| Multiple Myeloma |
1.6% |
| Osteoporosis |
1.6% |
| Blood Cholesterol Increased |
1.6% |
|
| Weight Decreased |
18.6% |
| Vomiting |
9.5% |
| White Blood Cell Count Decreased |
7.3% |
| Death |
6.4% |
| Renal Failure Acute |
5.5% |
| Thrombocytopenia |
5.2% |
| Pneumonia |
4.6% |
| Vitreous Haemorrhage |
4.6% |
| Drug Ineffective |
4.3% |
| Dyspnoea |
4.3% |
| Urinary Tract Infection |
3.4% |
| Wound |
3.4% |
| Wound Infection Staphylococcal |
3.4% |
| Fatigue |
3.0% |
| Oedema Peripheral |
3.0% |
| Fall |
2.7% |
| Pain |
2.7% |
| Rash |
2.7% |
| Renal Failure |
2.7% |
| Respiratory Failure |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
42.3% |
| Product Used For Unknown Indication |
16.3% |
| Hiv Infection |
9.8% |
| Arthralgia |
5.7% |
| Hypertension |
4.9% |
| Pulmonary Embolism |
4.1% |
| Back Pain |
3.3% |
| Convulsion |
3.3% |
| Atrial Fibrillation |
1.6% |
| Hypothyroidism |
1.6% |
| Aortic Valve Replacement |
0.8% |
| Arrhythmia |
0.8% |
| Bronchitis |
0.8% |
| Dyslipidaemia |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Pain |
0.8% |
| Prophylaxis |
0.8% |
| Tachycardia |
0.8% |
| Venous Insufficiency |
0.8% |
|
| International Normalised Ratio Decreased |
25.0% |
| Drug Interaction |
18.8% |
| Prescribed Overdose |
18.8% |
| Haematoma |
12.5% |
| Haemarthrosis |
6.3% |
| Overdose |
6.3% |
| Rectal Haemorrhage |
6.3% |
| Upper Gastrointestinal Haemorrhage |
6.3% |
|
